Disease X
placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on a shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic
Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen (e.g., broader vaccines and manufacturing facilities). Former Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses (e.g., flaviviruses), instead of just individual strains (e.g., zika virus), thus improving WHO capability to respond to unforeseen strains.
In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X. In December 2024, an unidentified disease in the Democratic Republic of the Congo, later revealed to be an aggressive strain of malaria, was sometimes referred to as Disease X after infecting over 400 people and killing at least 79.
Rationale
In May 2015, in pandemic preparations prior to the COVID-19 pandemic, the WHO was asked by member organizations to create an "R&D Blueprint for Action to Prevent Epidemics" to generate ideas that would reduce the time lag between the identification of viral outbreaks and the approval of vaccines/treatments, to stop the outbreaks from turning into a "public health emergency". The focus was to be on the most serious emerging infectious diseases (EIDs) for which few preventive options were available. A group of global experts, the "R&D Blueprint Scientific Advisory Group", was assembled by the WHO to draft a shortlist of less than ten "blueprint priority diseases".
Since 2015, the shortlist of EIDs has been reviewed annually and originally included widely known diseases such as Ebola and Zika which have historically caused epidemics, as well as lesser known diseases which have potential for serious outbreaks, such as SARS, Lassa fever, Marburg virus, Rift Valley fever, and Nipah virus. Since then, COVID-19 has been added to the list.
In February 2018, after the "2018 R&D Blueprint" meeting in Geneva, the WHO added Disease X to the shortlist as a placeholder for a "knowable unknown" pathogen.
The public source identifies “Disease X” as placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on a shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. This brief keeps that definition visible, then builds a research path around Disease, placeholder and name.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Disease X”, the useful work is to connect “placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on a shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic” to the records capable of establishing context and consequence.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Sep 24, 2026. The linked authority identifier is Q50410669. None of the 1 selected statements returned an explicit reference. The first chronological checks are 2018, 2020, 2024 and 2015.
Institutional narratives can privilege the records that survived while minimizing voices that were never formally collected. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “Disease X”, its source revision and the description used here.
- Expand the search: follow Disease X primary sources, Disease X archive and Disease research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Disease X”?
- Which voices are present, absent or mediated by the institution?
- What chronology connects this entry to wider political or social change?
Search terms from this dossier
This entry incorporates text from “Disease X” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.